Practice question

Answer the question and get instant feedback.

MediumEndocrinologyType 2 diabetes with cardiovascular diseaseca-mccqe1ca-ccfpca-rcpsc-im

A 64-year-old man with type 2 diabetes, eGFR 55 mL per minute per 1.73 m2, and prior myocardial infarction is on metformin and maximum-tolerated ACE inhibitor. HbA1c is 7.4 percent. According to Diabetes Canada and CCS recommendations, which additional glucose-lowering agent provides the greatest cardiovascular benefit?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.